Home / Brands / Lowlite Investments, Inc.
Lowlite Investments, Inc. Recalls
105 recalls on record · July 17, 2013 to July 17, 2013 · Drugs
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Glutathione 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Gentamicin Sulfate 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Gentamicin 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Gentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Gentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Gaba 50 mg/Mag Sulfate 50 mg/Taurine/Theanine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Fluphenazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Estradiol Cypionate 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Enrofloxacin 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Disodium EDTA Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Diphenhydramine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Diclazuril 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Dextrose 50% Solution, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Dexamethasone Sodium Phosphate 6 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Detomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Detomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Cre-O-Pan Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Clenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Chlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Ceftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Cal-Phos 1000 Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Caco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls BNP/Dexamethasone Eye Ointment, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes